#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13858	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2252	611.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1466	1466	C	827	C,T	769,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26518	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3632	727.8	0	.	n	.	0	T695C	SNP	695	695	T	1008	1008	C	798	C	742	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26518	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3632	727.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2284	2284	C	793	C	718	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26518	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3632	727.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2358	2358	A	759	A	718	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26518	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3632	727.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2910	2910	C	870	C	828	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1912	folP	855	855	100.0	folP.l15.c4.ctg.1	1632	116.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1027	1029	AGC	198;200;199	A;G;C	184;185;183	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4724	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3669	128.5	1	SNP	p	S91F	1	.	.	271	273	TTC	657	659	TTC	130;130;130	T;T;C	120;120;119	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4724	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3669	128.5	1	SNP	p	G95N	0	.	.	283	285	GGC	669	671	GGC	127;127;123	G;G,A;C	121;120,1;117	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4724	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3669	128.5	1	SNP	p	D95G	1	.	.	283	285	GGC	669	671	GGC	127;127;123	G;G,A;C	121;120,1;117	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1600	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1358	117.3	1	SNP	p	G45D	0	.	.	133	135	GGC	462	464	GGC	168;172;174	G;G;C	161;164;165	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	848	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1354	62.6	0	.	n	.	0	A197.	DEL	197	197	A	795	795	A	193	A	184	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4740	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3009	156.8	1	SNP	p	D86N	0	.	.	256	258	GAC	607	609	GAC	193;193;193	G;A;C	173;171;176	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4740	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3009	156.8	1	SNP	p	R87W	0	.	.	259	261	CGT	610	612	CGT	194;191;191	C;G;T	179;173;171	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4740	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3009	156.8	1	SNP	p	R87I	0	.	.	259	261	CGT	610	612	CGT	194;191;191	C;G;T	179;173;171	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4740	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3009	156.8	1	SNP	p	S87R	1	.	.	259	261	CGT	610	612	CGT	194;191;191	C;G;T	179;173;171	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4740	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3009	156.8	1	SNP	p	S88P	0	.	.	262	264	TCC	613	615	TCC	193;194;196	T;C;C	172;173;177	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3834	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2732	139.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1510	1512	GGC	174;174;173	G;G;C	166;166;164	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3910	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2365	164.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1257	1259	GCC	212;211;217	G;C,T;C	199;196,1;203	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3910	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2365	164.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1260	1262	ATG	218;216;218	A;T;G	202;200;203	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3910	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2365	164.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1272	1274	ACC	218;217;218	A;C;C	204;204;206	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3910	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2365	164.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1272	1274	ACC	218;217;218	A;C;C	204;204;206	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3910	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2365	164.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1773	1775	ACC	217;218;219	A;C;C	200;203;204	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3910	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2365	164.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1827	1829	GCG	216;215;214	G;C;G	200;200;196	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3910	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2365	164.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1827	1829	GCG	216;215;214	G;C;G	200;200;196	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3910	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2365	164.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1950	1952	GGT	185;185;185	G;G;T	166;168;167	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3910	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2365	164.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1959	1961	AGC	173;173;173	A;G;C,T	154;158;155,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3910	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2365	164.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1977	1979	CCG	153;157;157	C,G;C;GCCC,GGCCCCC,GGCCCC	121,2;121;118,1,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5480	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3089	176.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1616	1618	CCG	182;182;173	C;C;G	163;169;159	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2194	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1847	117.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	575	575	C	160	C	148	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	314	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1212	24.1	0	.	p	.	0	H217N	NONSYN	649	651	CAT	947	949	AAT	12;13;13	A;A;T	12;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	314	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1212	24.1	0	.	p	.	0	D218N	NONSYN	652	654	GAT	950	952	AAT	13;13;13	A;A;T	13;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	314	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1212	24.1	0	.	p	.	0	V226A	NONSYN	676	678	GTA	974	976	GCA	13;13;13	G;C;A	13;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	314	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1212	24.1	0	.	p	.	0	.	MULTIPLE	700	702	ACT	997	999	GTA	12;13;13	G;T;A	12;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	314	porB1a	984	287	91.07	porB1a.l6.c30.ctg.1	1212	24.1	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1006	1006	A	12	A	12	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2982	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1991	149.2	1	SNP	p	G120K	1	.	.	358	360	AAG	810	812	AAG	251;251;254	A;A;G	239;239;241	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2982	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1991	149.2	1	SNP	p	N121D	0	.	.	361	363	AAC	813	815	AAC	256;254;256	A;A;C,T	243;242;244,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2982	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1991	149.2	1	SNP	p	A121N	1	.	.	361	363	AAC	813	815	AAC	256;254;256	A;A;C,T	243;242;244,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11256	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4971	226.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1182	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1057	111.2	1	SNP	p	V57M	1	.	.	169	171	ATG	572	574	ATG	258;256;254	A;T;G	245;243;239	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
